Issue 31, 2009

Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer

Abstract

Nanoscale carriers are of increasing interest for use in anticancer therapy because they can deliver drugs in a targeted way. Ideally, nanocarriers combine passive and active delivery mechanisms, by integrating targeting ligands on the surface of their stealth corona using simple and efficient conjugation chemistry. This feature article summarizes the conventional and newly explored conjugation chemistries that are used to bind ligands in organic nanoparticle systems, providing strategic guidance for the preparation of targeted nanocarriers.

Graphical abstract: Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer

Article information

Article type
Feature Article
Submitted
11 Dec 2008
Accepted
09 Mar 2009
First published
09 Apr 2009

J. Mater. Chem., 2009,19, 5485-5498

Organic nanoscale drug carriers coupled with ligands for targeted drug delivery in cancer

M. Shi, J. Lu and M. S. Shoichet, J. Mater. Chem., 2009, 19, 5485 DOI: 10.1039/B822319J

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements